zika
viru
zikv
caus
agent
infecti
diseas
zika
fever
positivesens
rna
viru
belong
famili
flavivirida
genu
flaviviru
similar
dengu
viru
denv
yellow
fever
viru
japanes
enceph
viru
west
nile
viru
sikka
et
al
zikv
first
isol
rhesu
macaqu
uganda
previous
sporad
case
neglig
concern
associ
human
zikv
infect
report
hay
zikv
infect
becom
epidem
throughout
world
charrel
et
al
northeastern
state
brazil
public
health
author
recent
confirm
autochthon
transmiss
zikv
first
known
report
case
zikv
infect
mainland
south
america
campo
et
al
zanluca
et
al
follow
countri
includ
countri
european
union
outermost
region
america
barbado
bolivia
brazil
colombia
costa
rica
curacao
dominican
republ
ecuador
el
salvador
french
guiana
guadeloup
guatemala
guyana
haiti
hondura
jamaica
martiniqu
mexico
nicaragua
panama
paraguay
puerto
rico
saint
martin
surinam
us
virgin
island
venezuela
pan
american
health
organ
paho
world
health
organ
increas
frequenc
zikv
infect
among
world
travel
report
european
countri
includ
austria
denmark
finland
franc
germani
ireland
itali
portug
netherland
spain
sweden
switzerland
uk
european
centr
diseas
prevent
ecdc
virion
zikv
consist
approxim
kb
positivesens
rna
singl
capsid
two
membraneassoci
envelop
protein
e
leyssen
et
al
daep
et
al
charrel
et
al
recent
outbreak
zikv
infect
becom
fatal
daili
basi
america
obscur
viral
candid
place
forefront
global
healthcar
report
occurr
zikv
infect
thought
transmit
mainli
mosquito
speci
aed
aegypti
aed
albopictu
infect
dramat
increas
highli
popul
area
south
central
north
america
due
increas
frequenc
intern
travel
zikainfect
area
bogoch
et
al
consid
calam
zikv
infect
urgent
need
develop
rapid
detect
method
zikv
along
denv
share
common
clinic
symptom
zikv
purpos
review
provid
complet
updat
variou
analyt
method
viru
detect
molecular
immunolog
sensorbas
detect
assay
along
advantag
limit
strategi
furthermor
suggest
innov
hypothet
approach
develop
liposomebas
rapid
detect
assay
zikv
detect
provid
new
insight
medic
profession
control
widespread
epidem
viru
candid
zikv
emerg
flaviviru
share
common
clinic
symptom
denv
chikungunya
viru
chikv
outbreak
caus
virus
present
larg
number
diagnost
challeng
clinic
manifest
zikv
involv
similar
clinic
symptom
denv
chikv
includ
fever
exanthema
conjunct
retroorbit
headach
arthralgia
cardoso
et
al
diagnosi
viral
infect
specif
manag
implic
medic
personnel
identif
denv
requir
routin
followup
examin
thrombocyt
along
hematocrit
wherea
chikv
chronic
arthralgia
assess
due
high
preval
case
zikv
detail
diagnosi
sexual
maternalfet
transmiss
perform
confirm
risk
congenit
microcephali
newborn
babi
fauci
moren
varieti
arbovir
infect
arthropodborn
denv
common
arbovir
infect
may
similar
clinic
present
therefor
circul
may
underreport
specif
diagnost
tool
implement
howev
sever
drawback
zikv
diagnosi
due
lack
avail
diagnost
tool
frequent
crossreact
antibodi
flavivirus
result
sever
limit
use
serolog
musso
et
al
commonli
routin
test
viru
cultur
perform
antigen
detect
test
lack
present
musso
et
al
saiz
et
al
symptom
zikv
infect
usual
tend
mild
initi
symptom
escap
notic
reduc
opportun
collect
sampl
although
virem
period
complet
defin
viral
rna
detect
serum
onset
symptom
day
addit
rna
particl
zikv
detect
urin
extend
period
acut
phase
lead
possibl
consid
altern
sampl
type
evid
suggest
serum
sampl
taken
first
day
onset
symptom
support
detail
studi
musso
et
al
symptom
microcephali
associ
zikv
develop
newborn
uteru
report
oduyebo
et
al
diagnosi
infant
microcephali
complet
analysi
head
circumfer
request
kallen
diagnost
paramet
sever
microcephali
includ
head
circumfer
standard
deviat
mean
von
der
hagen
et
al
test
perform
pregnant
women
posit
inconclus
result
zikv
test
diagnost
paramet
confirm
possibl
congenit
zikv
infect
infant
clinic
evalu
perform
followup
fever
common
present
symptom
patient
test
posit
arbovirus
due
associ
multipl
ill
henc
suggest
elimin
differenti
diagnos
kelser
patient
denv
zikv
present
temperatur
respect
zikv
usual
selflimit
symptom
last
day
jaundic
distinguish
clinic
present
yellow
fever
viru
aid
identifi
patient
zikv
viru
presenc
nausea
vomit
bleed
may
help
identifi
denv
symptom
individu
expos
zikv
indic
possibl
zikv
infect
immedi
serum
test
therefor
perform
center
diseas
control
prevent
cdc
b
molecular
detect
virus
twostep
process
includ
viru
detect
propag
cell
cultur
viral
genomebas
detect
molecular
amplif
use
polymeras
chain
reaction
pcr
realtim
pcrbase
detect
method
propag
cell
detect
viru
confirm
cytopath
effect
cell
cultur
posit
result
confirm
use
tissu
cultur
infecti
dose
plaqu
assay
hamza
et
al
last
sever
year
revolut
viru
detect
method
use
realtim
pcr
base
assay
perform
rapidli
produc
specif
sensit
reproduc
result
viru
detect
low
concentr
sanchez
et
al
paramet
interconnect
depend
mostli
target
sequenc
primer
probe
provid
absolut
specif
balanc
high
sensit
broad
reactiv
reliabl
quantif
seifi
et
al
polymeras
chain
reactionbas
method
numer
advantag
compar
convent
assay
method
rapid
quantit
measur
low
contamin
rate
easi
standard
sanchez
et
al
seifi
et
al
although
realtim
revers
transcript
pcr
assay
avail
detect
micronesian
zikv
strain
africa
asia
cover
genet
divers
geograph
distribut
zikv
hay
current
diagnost
techniqu
zikv
infect
timeconsum
mainli
base
specif
detect
antibodi
isol
virus
anim
mosquito
digoutt
et
al
hay
fay
et
al
howev
standard
pcrbase
techniqu
realtim
pcr
quantit
realtim
pcr
provid
rapid
specif
sensit
method
earli
detect
zikv
foy
et
al
fay
et
al
develop
quantit
realtim
pcr
assay
detect
zikv
mosquito
field
high
analyt
sensit
found
assay
abl
detect
zikv
isol
find
confirm
use
realtim
revers
transcript
pcr
assay
could
use
tool
detect
zikv
viru
pandem
area
virus
includ
denv
chikv
also
occur
fay
et
al
calvet
et
al
develop
realtim
quantit
pcr
assay
detect
zikv
pregnant
women
use
viral
metagenom
gene
sequenc
analysi
realtim
quantit
pcr
analysi
confirm
develop
assay
abl
detect
zikv
infect
amniot
fluid
howev
assay
show
neg
result
detect
zikv
infect
urin
serum
sampl
escadaf
et
al
test
efficaci
recombin
polymeras
amplif
assay
detect
yellow
fever
viru
use
nucleic
acid
detect
method
confirm
posit
result
detect
denv
also
confirm
use
recombinas
polymeras
amplif
assay
support
suggest
assay
could
use
tool
detect
zikv
wahe
et
al
due
rapid
global
increas
zikv
concern
rapid
increas
microcephali
case
newborn
develop
specif
sensit
pointofcaretest
method
becom
major
public
health
prioriti
sikka
et
al
zikv
share
common
platform
clinic
manifest
denv
chikv
specif
sensit
onestep
realtim
pcr
assay
test
presenc
zikv
dengu
chikungunyaneg
sera
sampl
collect
patient
repres
denvlik
ill
singapor
balm
et
al
assay
display
specif
detect
zikv
low
detect
limit
copi
viral
rna
suggest
assay
could
use
viral
detect
varieti
environment
sampl
balm
et
al
recent
waggon
et
al
develop
evalu
multiplex
realtim
revers
transcript
pcr
assay
simultan
detect
zikv
develop
assay
improv
detect
limit
zikv
rel
correspond
realtim
revers
transcript
pcr
assay
sampl
found
posit
zikv
waggon
et
al
find
studi
suggest
improv
sensit
zikv
detect
need
given
low
viremia
detect
clinic
sampl
current
lack
accur
altern
diagnost
serolog
lanciotti
et
al
musso
et
al
addit
develop
assay
identifi
coinfect
zikvposit
patient
suggest
potenti
applic
multiplex
diagnost
test
viral
detect
furthermor
kilianski
et
al
develop
unamplifi
rnacomplementari
dna
cdna
hybrid
nanopor
sequenc
assay
detect
rna
virus
includ
middl
east
respiratori
syndrom
venezuelan
equin
enceph
viru
ebola
zikv
develop
method
abl
detect
venezuelan
equin
enceph
viru
within
hour
acquisit
achiev
differenti
viral
genom
facilit
strainlevel
identif
nanopor
sequenc
novel
genom
technolog
potenti
applic
routin
biosurveil
clinic
diagnosi
outbreak
investig
viru
infect
rapid
sequenc
unamplifi
rnacdna
hybrid
kilianski
et
al
sequenc
unamplifi
poli
tail
viral
rna
use
rapid
cdna
librari
prepar
coupl
realtim
data
analysi
determin
potenti
applic
pathogen
genom
character
approach
pathogen
identif
character
differ
previous
use
method
minion
platform
hoenen
et
al
bias
techniqu
amplicon
sequenc
proven
effect
complex
sampl
background
titer
target
pathogen
might
low
approach
limit
character
known
pathogen
requir
addit
viral
genom
amplif
wang
et
al
quick
et
al
great
potenti
use
rnacdna
hybrid
approach
field
studi
confirm
western
africa
hoenen
et
al
quick
et
al
gener
high
viru
titer
clinic
sampl
necessari
viru
detect
genom
sequenc
henc
util
rnacdna
hybrid
approach
genom
zikv
character
could
feasibl
strategi
especi
genom
librari
prepar
reduc
time
requir
strainlevel
identif
faria
et
al
although
pcrbase
molecular
techniqu
aid
easi
detect
varieti
virus
still
sever
limit
method
note
method
prone
miss
detect
favor
fals
neg
result
requir
proper
qualiti
control
measur
howev
precaut
taken
overcom
problem
inhibit
includ
sampl
dilut
analysi
use
small
sampl
size
adapt
pcr
assay
employ
chemic
reagent
tween
alsoud
radstrom
rutj
et
al
butot
et
al
anoth
limit
pcrbase
method
inabl
differenti
infecti
noninfecti
virus
although
sever
approach
use
overcom
limit
util
integr
system
base
molecular
detect
virus
cell
cultur
infect
consid
one
effici
methodolog
reynold
et
al
rodriguez
et
al
addit
integr
cell
culturepcr
assay
allow
rapid
viru
detect
select
enumer
infecti
virus
though
long
incub
period
requir
reveal
cytopath
effect
major
limit
aim
synthet
biolog
focus
reengin
molecular
compon
cell
exploit
power
biolog
molecular
biologist
develop
wholecel
biosensor
synthet
probiot
candid
new
drug
sourc
green
technolog
chemic
resourc
zhang
et
al
torella
et
al
fossati
et
al
kotula
et
al
recent
report
paper
disk
diagnost
tool
show
signific
efficaci
rapid
lowcost
screen
tool
screen
blood
urin
saliva
sampl
specif
identif
viru
strain
assay
methodolog
base
color
chang
paper
disk
purpl
indic
presenc
viru
yellow
absenc
viru
recent
parde
et
al
report
biotechnolog
paramet
dramat
lower
cost
technic
barrier
develop
synthet
biologybas
diagnost
regard
programm
rna
sensor
refer
toehold
switch
could
first
technolog
ration
appli
bind
virtual
sens
rna
sequenc
green
et
al
second
freezedri
paperbas
cellfre
protein
express
platform
allow
applic
toehold
switch
sensor
outsid
laboratori
provid
abiot
steril
method
distribut
storag
genet
circuit
room
temperatur
parde
et
al
concern
find
combin
techniqu
could
provid
rapid
inexpens
platform
develop
easytous
viru
diagnost
sensor
context
zikv
outbreak
paperbas
sensor
offer
solut
critic
challeng
involv
diagnosi
viru
standard
serolog
methodolog
involv
antibodi
detect
present
limit
due
crossreact
flavivirus
detect
previous
infect
patient
thu
nucleic
acidbas
isotherm
nucleic
acid
amplif
detect
method
recommend
accur
detect
virus
lanciotti
et
al
tapp
et
al
zammarchi
et
al
howev
techniqu
rel
expens
requir
technic
expertis
run
interpret
involv
equip
incompat
use
remot
lowresourc
locat
surveil
contain
critic
need
current
zikv
outbreak
repres
great
threat
specif
pregnant
women
antibodi
respons
pregnanc
stage
may
differ
nonpregn
individu
precaut
taken
determin
zikv
immun
respons
pregnant
women
flaviviru
infect
immunoglobulin
igm
antibodi
typic
develop
within
day
onset
ill
gener
detect
three
month
charrel
et
al
addit
immunoglobulin
g
igg
antibodi
develop
within
day
develop
igm
antibodi
detect
sever
month
recent
februari
center
diseas
control
prevent
cdc
request
letter
issu
author
emerg
use
zika
igm
antibodi
captur
enzymelink
immunosorb
assay
zika
macelisa
presumpt
detect
zikvspecif
igm
human
sera
cerebrospin
fluid
center
diseas
control
prevent
cdc
zika
macelisa
employ
vitro
qualit
detect
zikvspecif
igm
antibodi
human
sera
addit
test
zikv
appli
base
cdc
clinic
epidemiolog
criteria
zikv
includ
clinic
sign
symptom
associ
zikv
infect
andor
histori
resid
travel
geograph
region
activ
zikv
transmiss
time
travel
epidemiolog
criteria
may
indic
zikv
test
center
diseas
control
prevent
cdc
report
previous
immun
respons
zikv
infect
describ
small
number
patient
n
zikv
viru
outbreak
yap
lanciotti
et
al
macelisa
igm
captur
elisa
igg
whole
viral
antigen
inactiv
viru
monoclon
antibodi
mab
appli
igm
found
appear
soon
day
onset
symptom
igg
appear
day
patient
histori
previou
flaviviru
infect
johnson
et
al
martin
et
al
subsequ
becam
possibl
detect
neutral
antibodi
zikv
earli
day
onset
fever
euroimmun
develop
first
complet
test
packag
serolog
detect
zikv
infect
elisa
indirect
immunofluoresc
assay
allow
determin
specif
antibodi
igm
igg
varieti
virus
blood
infect
patient
huzli
et
al
report
use
put
cross
react
sera
elisa
test
patient
euroimmun
antizikv
igg
igm
antibodi
zikv
show
high
specif
confirm
applic
euroimmun
elisa
specif
detect
viru
patient
expos
previous
flaviviru
vaccin
result
suggest
elisa
method
could
effect
diagnost
tool
screen
counsel
patient
possibl
zikv
viru
infect
especi
pregnant
women
travel
commut
zikvendem
region
huzli
et
al
confirm
abil
zikv
elisa
detect
zikv
antibodi
tapp
et
al
analyz
serum
sampl
collect
patient
brazil
suffer
acut
zikv
infect
laboratori
result
confirm
indirect
immunofluoresc
assay
abl
defin
immunofluoresc
assay
titer
antizikv
igm
antizikv
igg
tapp
et
al
sampl
previous
confirm
neg
igm
igg
denv
denv
nonstructur
denv
antigen
along
zikv
denv
yellow
fever
anoth
acut
viral
infect
transmit
mosquito
bite
strongli
believ
current
emerg
reemerg
yellow
fever
arbovirus
partli
attribut
increas
migrat
peopl
diseaseendem
region
expand
establish
vector
use
flaviviru
antigen
develop
mab
diagnost
test
well
document
vazquez
et
al
nune
et
al
okamoto
et
al
kwallah
et
al
escadaf
et
al
applic
mab
immunoassay
offer
advantag
high
specif
due
abil
bind
specif
epitop
antigen
specif
bind
use
reduc
incid
crossreact
report
neg
impact
use
mani
serolog
kit
modi
et
al
adungo
et
al
also
report
develop
character
evalu
mab
yellow
fever
viru
diagnost
applic
mab
test
antigen
detect
igm
captur
elisa
result
suggest
mabbas
antigen
detect
elisa
enabl
detect
viru
cultur
supernat
contain
titer
approxim
plaqu
form
unit
pfu
concern
find
develop
approach
appli
develop
improv
detect
kit
zikv
one
limit
test
possibl
fals
posit
result
patient
histori
infect
flavivirus
addit
test
equivoc
posit
specimen
andor
patientmatch
specimen
specifi
cdcissu
algorithm
therefor
requir
confirm
zikv
infect
center
diseas
control
prevent
cdc
zika
fever
zoonot
infect
caus
zikv
share
limelight
wellknown
member
flaviviru
famili
denv
yellow
fever
viru
west
nile
viru
japanes
enceph
viru
tilak
et
al
consequ
urgent
need
develop
effect
method
surveil
zikv
zikv
denv
share
sequenti
homolog
high
possibl
may
detect
principl
vaccin
develop
strategi
applic
virus
modif
one
approach
could
use
detect
denv
involv
concentr
viru
particl
use
ultracentrifug
polyethylen
glycolmedi
precipit
although
method
use
success
varieti
virus
ultracentrifug
show
numer
practic
limit
great
amount
time
requir
may
increas
falseposit
rate
appli
pcr
analysi
roth
et
al
regard
polyethylen
glycolmedi
precipit
although
simpl
easi
perform
interfer
subsequ
pcr
analysi
novotni
et
al
possibl
altern
method
could
applic
magnet
bead
coat
molecul
effici
bind
viru
bead
allow
viral
particl
captur
assist
concentr
viral
particl
applic
magnet
field
number
magnet
nanoparticl
iron
nickel
cobalt
success
use
biomed
environment
applic
due
highlyspecif
surfac
area
eas
magnet
collect
target
materi
adsorb
magnet
nanoparticl
safarikova
safarik
pankhurst
et
al
howev
bead
gener
exhibit
inher
chemic
instabl
limit
applic
field
biolog
environment
scienc
saraswati
et
al
overcom
limit
magnet
nanoparticl
typic
encapsul
protect
shell
graphit
silica
polym
chemic
stabil
saraswati
et
al
similarli
sakudo
et
al
develop
novel
technolog
sensit
detect
denv
use
graphiteencapsul
magnet
nanoparticl
conjug
antidenv
antibodi
assay
method
demonstr
antibodyintegr
magnet
bead
use
captur
denv
captur
use
antibodyintegr
magnet
bead
confirm
result
realtim
pcr
analysi
show
captur
fraction
contain
denv
genom
rna
sakudo
et
al
therefor
method
may
use
combin
realtim
pcr
detect
denv
may
increas
sensit
viral
detect
diagnosi
denv
base
find
hypothes
methodolog
could
extend
accur
detect
zikv
immobil
antizikv
antibodi
function
surfac
graphit
magnet
nanoparticl
modifi
graphit
magnet
nanoparticl
assess
abil
captur
zikv
concentr
viru
subsequ
detect
applic
pcrbase
amplif
procedur
case
hydrophob
graphiteencapsul
magnet
nanoparticl
present
limit
variou
biomed
applic
particl
modifi
appropri
achiev
improv
bind
properti
allow
effici
recogn
bind
molecular
target
includ
antibodi
antigen
receptor
poplawska
et
al
improv
amino
group
function
increas
reactiv
hydrophob
natur
graphit
particl
desir
function
graphit
saraswati
et
al
promis
method
amino
function
magnet
graphit
nanoparticl
could
use
induct
coupl
radiofrequ
plasma
environment
friendli
method
requir
short
durat
reaction
reach
complet
thu
effect
introduc
amino
group
saraswati
et
al
furthermor
alter
plasma
discharg
condit
help
optim
degre
surfac
derivat
amino
group
graphit
magnet
nanoparticl
modif
graphit
magnet
nanoparticl
effici
surfac
immobil
antibodi
variou
pathogen
includ
antiinfluenza
viru
antisalmonella
antibodi
could
achiev
sakudo
et
al
recent
tian
et
al
develop
attomolar
zikv
oligonucleotid
detect
method
base
loopmedi
isotherm
amplif
susceptometri
demonstr
hydrodynam
volum
streptavidinmagnet
nanoparticl
dramat
increas
success
loopmedi
isotherm
amplif
reaction
hydrodynam
volum
probe
brownian
relax
frequenc
shift
employ
quantifi
zikv
oligonucleotid
propos
detect
system
recogn
synthet
zikv
oligonucleotid
serum
total
assay
time
min
result
suggest
could
promis
strategi
may
give
rise
new
possibl
diagnos
control
zikv
infect
increas
incid
dengu
infect
develop
countri
denv
endem
rapid
applic
diagnost
test
requir
diseas
control
sever
immunolog
approach
appli
laboratori
diagnosi
denv
infect
method
includ
detect
viru
cell
cultur
immunofluorescencebas
detect
viru
antigen
elisa
detect
antidenv
antibodi
hemagglutin
inhibit
complement
fixat
test
neutral
test
detect
viru
nucleic
acid
realtim
revers
transcriptionpcr
hemagglutin
inhibit
wide
accept
serolog
techniqu
develop
countri
howev
elisa
becom
techniqu
often
appli
serolog
diagnosi
denv
infect
denv
epidem
region
due
stabil
simpl
handl
procedur
need
complic
equip
character
detect
virus
laborintens
timeconsum
process
upon
emerg
new
viral
pathogen
high
frequenc
catastroph
outbreak
alway
need
improv
detect
identif
method
control
prolifer
pandem
viral
candid
current
laboratori
scale
pcrbase
molecular
techniqu
provid
accur
detect
varieti
virus
base
trialanderror
method
use
cell
culturebas
procedur
pcrbase
method
requir
thermal
cycl
instrument
transform
denvzikv
genom
rna
dna
kow
et
al
zaytseva
et
al
zaytseva
et
al
develop
multianalyt
singlemembran
biosensor
serotypespecif
detect
denv
show
reliabl
denv
serotyp
determin
assay
exhibit
detect
limit
rna
molecul
serotyp
rna
molecul
serotyp
rna
molecul
serotyp
follow
isotherm
amplif
target
sequenc
develop
biosensor
consid
applic
portabl
inexpens
easi
use
tool
repres
altern
current
detect
method
base
expens
timeconsum
method
elisa
tissu
cultur
although
techniqu
readili
avail
expens
present
engin
challeng
regard
miniatur
field
util
addit
pcr
product
consist
doublestrand
dna
must
denatur
subject
probe
hybridizationbas
detect
method
baeumner
et
al
contrast
biosensor
base
liposom
technolog
success
use
develop
rapid
inexpens
fieldutiliz
detect
system
potenti
detect
quantif
rna
molecul
esch
et
al
provid
updat
develop
liposomebas
detect
method
denv
zikv
two
virus
share
major
genet
inform
liposomebas
immunoassay
show
applic
variou
area
food
chemistri
food
microbiolog
nanobiotechnolog
diagnost
clinic
microbiolog
detect
foodborn
pathogen
toxin
hazard
compon
varieti
environment
human
sampl
liposom
immunoassay
involv
liposomeencapsul
marker
prepar
phospholipid
composit
coupl
either
analyt
antibodi
suitabl
procedur
shukla
et
al
variou
recent
advanc
method
relat
liposom
immunoassay
includ
immunoliposom
liposom
coupl
antibodi
base
elisa
immunoliposomebas
magnet
separ
liposomebas
immunochromatograph
strip
use
variou
pathogen
detect
applic
baeumner
et
al
develop
liposom
biosensorbas
method
detect
denv
sensit
rapid
serotyp
specif
biosensor
assay
base
util
membranebas
dnarna
hybrid
system
liposom
amplif
gener
dna
probe
coupl
dyeencapsul
liposom
conserv
denv
serotypespecif
probe
immobil
polyeth
sulfon
membran
strip
liposom
mix
amplifi
target
sequenc
appli
membran
mixtur
allow
migrat
along
test
strip
liposom
target
sequenc
complex
immobil
captur
zone
via
hybrid
captur
probe
target
sequenc
amount
liposom
present
immobil
complex
directli
proport
amount
target
sequenc
present
sampl
quantifi
use
portabl
reflectomet
baeumner
et
al
connelli
et
al
also
develop
method
involv
microfluid
preconcentr
coupl
liposomebas
signal
amplif
effici
detect
virus
environment
water
clinic
sampl
subsequ
electrochem
liposomebas
assay
develop
facilit
direct
detect
virusliposomebead
complex
use
magnet
connelli
et
al
integr
current
signal
lysi
captur
liposom
result
detect
viral
titer
environment
sampl
although
number
establish
liposomebas
method
avail
detect
differ
virus
variou
sampl
specif
sensit
liposomebas
detect
method
develop
zikv
number
liposomebas
assay
also
use
biomed
therapeut
applic
clinic
diagnost
assay
pathogen
detect
liposomebas
later
flow
assay
coupl
nucleic
acid
sequencebas
amplif
prove
repres
effect
altern
rapid
sensit
detect
viabl
bacteri
pathogen
hartlefi
baeumner
baeumner
et
al
edward
et
al
develop
fluoresc
dyeencapsul
liposom
tag
dna
aptam
use
detect
alphathrombin
via
aptamerbas
assay
human
plasma
advantag
dna
aptam
antibodi
includ
stabil
product
via
inexpens
consist
chemic
synthesi
eas
modif
term
label
select
chang
sequenc
achiev
affin
select
enhanc
stabil
potenti
regener
smaller
size
product
toxic
poorli
immunogen
target
tombelli
et
al
balamurugan
et
al
assay
dyeencapsul
liposom
use
signal
enhanc
provid
extrem
low
detect
limit
assay
addit
fluoresc
marker
enzym
liposom
use
encapsul
varieti
electrochem
marker
feng
et
al
other
sofou
sgouro
sajja
et
al
develop
demonstr
util
bifunct
immunoliposom
system
target
glioma
cell
vitro
vivo
provid
potenti
drug
deliveri
imag
tumor
lehtinen
et
al
also
report
immunotarget
system
involv
liposom
drug
carrier
treat
ovarian
carcinoma
addit
immunoliposom
use
deliv
contrast
agent
radionuclid
diagnost
imag
therapi
torchilin
erdogan
et
al
semiconductor
quantum
dot
conjug
liposom
use
imag
immunoliposom
success
observ
vitro
vivo
weng
et
al
subtitl
intend
elucid
varieti
way
liposom
use
analyt
reagent
date
method
reli
tag
liposom
could
provid
numer
way
signal
molecul
releas
provid
signal
therefor
state
liposomesimmunoliposom
show
potenti
applic
variou
industri
medic
sector
includ
viru
detect
liposom
immunoassay
futur
consider
commerci
serolog
test
becom
increasingli
avail
detect
varieti
virus
knowledg
commerci
test
expect
hit
commerci
market
near
futur
zikv
igg
igm
elisa
kit
base
util
doubleantigen
sandwich
elisa
introduc
mybiosourc
usa
howev
inform
type
antigen
involv
specif
valid
determin
crossreact
avail
biocon
diagnost
canada
offer
rapid
fingerprick
assay
base
mixtur
zikv
envelop
protein
detect
igm
igg
viral
antibodi
compani
indic
specif
specif
regard
valid
procedur
given
euroimmun
germani
offer
igmigg
immunofluoresc
assay
igmigg
elisa
base
protein
zikv
immunofluoresc
assay
offer
mosaic
slide
togeth
assay
chikv
provid
inform
indic
crossreact
antibodi
direct
tickborn
enceph
viru
west
nile
viru
denv
igg
igm
assay
charrel
et
al
furthermor
valid
data
indic
wide
rang
specif
sensit
igm
igg
zikv
immunofluoresc
assay
depend
valid
cohort
howev
provid
valu
difficult
interpret
descript
cohort
brief
addit
data
interpret
great
caution
posit
rate
cutoff
dilut
could
mean
specif
differ
given
higher
result
score
endtit
use
endtit
would
provid
window
differenti
crossreact
measur
euroimmun
zikv
elisa
base
recombin
protein
lead
reduct
crossreact
flaviviru
antibodi
maxim
valu
igg
igm
euroimmun
appear
manufactur
actual
provid
detail
valid
data
data
clearli
address
illustr
abovement
difficulti
crossreact
flaviviru
serodiagnost
euroimmun
musso
et
al
perform
molecular
detect
zikv
saliva
sampl
rna
extract
use
system
accord
manufactur
recommend
extract
rna
use
realtim
pcr
detect
system
use
two
realtim
primersprob
amplif
set
specif
zikv
musso
et
al
analysi
confirm
posit
result
blood
sampl
posit
result
saliva
sampl
overal
number
realtim
pcrposit
zikv
sampl
suggest
zikv
rna
frequent
detect
saliva
sampl
blood
sampl
musso
et
al
updat
inform
newli
develop
commerci
detect
kit
zikv
detect
given
tabl
limit
current
diagnost
test
zikv
describ
previous
consider
highlight
technic
challeng
test
develop
limit
scientif
understand
viru
stage
zikv
respons
previou
work
report
polyclon
antibodi
product
purif
applic
variou
liposomebas
assay
shukla
et
al
current
avail
studi
liposomebas
assay
detect
zikv
studi
denv
avail
base
liposom
consid
variou
assay
develop
denv
virus
propos
strategi
develop
liposomebas
assay
detect
zikv
thu
specif
liposomebas
assay
appli
develop
liposom
particl
develop
liposomebas
detect
system
analyz
zikv
clinic
sampl
use
antizikv
antibodi
sever
report
describ
principl
variou
liposomebas
assay
detect
pathogen
shin
kim
shukla
et
al
liposom
immunoassay
involv
liposomeencapsul
marker
sulforhodamin
b
dye
prepar
phospholipid
composit
coupl
either
analyt
antibodi
suitabl
procedur
shukla
et
al
assay
carri
routin
manner
detect
signal
assay
produc
upon
lysi
liposom
releas
encapsul
marker
shin
kim
report
size
liposom
increas
higher
fluoresc
signal
obtain
due
greater
number
sulforhodamin
b
molecul
encapsul
liposom
variou
advanc
method
relat
immunoliposom
assay
recent
develop
includ
immunoliposomecoupl
elisa
immunoliposomecoupl
magnet
separ
immunoliposomebas
immunochromatograph
strip
use
variou
applic
predict
model
liposomebas
immunochromatograph
strip
viral
detect
summar
figur
briefli
assay
involv
antigen
captur
zone
test
line
nitrocellulos
membran
strip
expos
target
antigen
consist
viru
particl
solut
contain
immunoliposom
liposom
encapsul
sulforhodamin
b
tag
antizikv
antibodi
specif
bind
specif
zikv
particl
presenc
zikv
particl
immunoliposom
zikv
particl
complex
migrat
along
test
strip
via
capillari
action
subsequ
bind
captur
antibodi
zone
membran
produc
purpl
band
howev
immunoliposom
bind
zikv
particl
test
line
continu
migrat
bind
control
line
membran
result
develop
purpl
band
show
posit
result
presenc
zikv
particl
figur
absenc
zikv
particl
test
sampl
immunoliposom
abl
bind
specif
antigen
zikv
therefor
migrat
bind
control
line
test
membran
lead
develop
purpl
line
control
line
confirm
neg
result
zikv
particl
detect
figur
addit
anoth
simpl
liposomebas
detect
strategi
util
liposom
immunoassay
detect
measur
via
lysi
liposom
particl
shukla
et
al
sulforhodamin
b
selfquench
molecul
encapsul
high
concentr
within
lipid
phospholipid
vesicl
form
sulforhodamin
bencapsul
liposom
therefor
integr
sulforhodamin
bencapsul
antibodytag
liposom
target
viru
particl
determin
measur
increas
fluoresc
lysi
immunoliposom
particl
figur
furthermor
might
anoth
strategi
develop
combin
assay
involv
immunoliposom
immunomagnet
particl
sensit
detect
zikv
particl
shown
figur
assay
procedur
divid
follow
three
step
immunomagnet
concentr
separ
target
zikv
reaction
immunoliposom
particl
viru
particl
attach
immunomagnet
nanoparticl
fluoresc
signal
gener
principl
develop
assay
discuss
earlier
research
shukla
et
al
anoth
import
possibl
develop
liposomebas
multiplex
would
allow
simultan
detect
sever
similar
gene
sequenc
viral
pathogen
singl
sampl
particularli
zikv
denv
chikv
addit
zikv
denv
chikv
choic
pathogen
multiplex
diagnost
tool
consid
clinic
consist
present
pathogen
relev
set
nonetheless
need
differenti
chikv
denv
zikv
clinic
epidemiolog
purpos
immedi
import
like
remain
relev
futur
multiplex
assay
particularli
measur
rna
chikv
denv
zikv
import
analyt
sensit
zikv
compromis
possibl
interpret
multiplex
liposomebas
kit
involv
immunochromatograph
strip
illustr
figur
obtain
accur
result
multiplex
assay
may
base
liposomebas
immunochromatograph
strip
develop
common
antibodi
zikv
denv
chikv
might
provid
use
result
multiplex
test
abl
detect
zikv
antibodi
case
concurr
infect
pathogen
analyt
limit
detect
zikv
antibodi
singleplex
multiplex
test
multiplex
use
dual
analyt
singl
test
eg
nucleic
acid
immunoassay
test
chen
zhu
may
also
greatli
improv
diagnosi
acut
zikv
infect
exampl
test
could
simultan
detect
zikv
rna
antizikv
igm
would
cover
entir
time
period
acut
zikv
infect
might
particularli
use
given
limit
reliabl
patient
selfreport
onset
fever
symptom
although
antibodybas
zikv
detect
kit
avail
present
potenti
easi
method
develop
pathogen
detect
kit
base
laboratoryproduc
antibodi
liposom
could
provid
cheaper
altern
pathogen
detect
compar
expens
commerci
pathogen
detect
kit
near
futur
studi
attempt
confirm
practic
applic
liposomebas
viru
detect
assay
variou
food
sampl
contamin
foodborn
virus
includ
zikv
regard
laboratori
safeti
zikv
classifi
biolog
safeti
level
pathogen
agent
pathogen
must
handl
accord
biosafeti
guidelin
microbiolog
biomed
laboratori
risk
assess
perform
laboratori
specif
procedur
use
laboratori
major
concern
regard
congenit
microcephali
zikv
infect
precaut
taken
pregnant
women
work
laboratori
regular
zikv
test
maintain
laboratori
cdc
recommend
laboratori
perform
risk
assess
implement
new
viral
methodolog
laboratori
safeti
precaut
center
diseas
control
prevent
cdc
widespread
zikv
epidem
america
asia
led
urgent
need
develop
rapid
sensit
specif
assay
viru
detect
regular
monitor
viral
infect
rapid
detect
viru
fieldcollect
specimen
acceler
applic
appropri
mosquito
control
measur
could
prevent
transmiss
diseas
among
human
popul
earli
diagnosi
zikv
infect
support
care
symptomat
treatment
referr
children
microcephali
special
care
necessari
measur
improv
neurodevelop
affect
children
hypothesi
strategi
present
herein
provid
relev
platform
emphas
import
liposomebas
detect
method
zikv
diagnosi
improv
global
health
overal
view
best
advantag
hypothes
assay
easi
handl
requir
sophist
instrument
rapid
detect
efficaci
cost
effect
molecular
approach
side
major
limit
factor
hypothes
assay
especi
detect
viral
infect
includ
zikv
denv
other
antigenantibodybas
detect
abil
identif
major
antigen
protect
epitop
target
viru
particl
importantli
need
understand
antibodi
respons
develop
detect
strategi
brief
viru
particl
easili
go
mutat
antigen
variat
infecti
viru
alter
surfac
protein
call
antigen
structur
eventu
result
differenti
viru
strain
antigen
variat
make
difficulti
process
specif
antibodi
product
thu
may
affect
development
process
diagnost
assay
conclus
present
review
summar
updat
method
avail
detect
zikv
human
clinic
sampl
new
insight
interpret
obtain
studi
mechan
sever
similar
detect
strategi
develop
innov
approach
base
liposom
particl
interest
detect
zikv
particularli
relat
previous
develop
liposomebas
strategi
may
provid
new
insight
futur
research
strategi
develop
fast
sensit
assay
zikv
infect
mk
ss
conceiv
design
review
theme
syh
shc
help
write
review
paper
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
